Answers are grounded in this paper and cite their sources.
This study aimed at developing a lignin-based bio-binder from organosolv lignin extracted from mixed wood sawdust composed of three local wood species, namely Cordia, Iroko, and Passi, collected in Ngaoundéré, Cameroon, for application in particleboard manufacturing. The mixed sawdust was first sampled and characterized. Lignin was then extracted using the organosolv process, characterized, and modified by phenolation. The bio-binder formulation was optimized using response surface methodology based on a central composite design with three factors (lignin, furfural, and glycerol) and four responses (pH, viscosity, gel time, and insoluble fraction). The optimized bio-binder was subsequently used in the manufacturing process of particleboards produced from the mixed sawdust. The results showed that the mixed sawdust contained 45.6% lignin, with an extraction yield of 55.75% and a lignin purity of 91.1%. The optimized bio-binder exhibited a pH of 5.1, a viscosity of 342 mPa·s, a gel time of 3.35 min, and an insoluble fraction of 79.56%. The optimized particleboard exhibited a thickness swelling of 2.94%, an impact resistance of 100%, and a water absorption of 254%. Finally, the developed bio-binder contains 87.6% wood sawdust. When incorporated at 8.00% into particleboards containing 90.48% sawdust, it results in a final material with a wood sawdust content of 97.28%. These findings highlight the economic and industrial potentials of mixed wood sawdust as an abundant and readily available resource for the development of lignin-based bio-binders and more sustainable particleboards in Cameroon to promot local technology and economic development.
No takes yet. Share an insight, caveat, or question.
Nduimo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: